Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Dyspnoea, Headache
Clinical narrative: Extreme joint pain and inflammation.; Extreme joint pain and inflammation.; Extreme headaches; nausea; back pain; Swollen joints; increased stiffness in all joints, but the wrists, shoulder and hips are the worst; Difficulty breathing; low energy; heart palpitations; wheezing; Dose: 1; Date: 13Mar2021/Dose: 2; Date: 13Mar2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 13Mar2021 (Lot number: EP7531) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "MS" (unspecified if ongoing); "CVID" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Batch/Lot No: EP7534, Location of injection: Arm Right), administration date: 13Mar2021, for Covid-19 immunisation.  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 2021, outcome "unknown", described as "Dose: 1; Date: 13Mar2021/Dose: 2; Date: 13Mar2021"; ARTHRALGIA (non-serious), INFLAMMATION (non-serious) all with onset 15Mar2021, outcome "not recovered" and all described as "Extreme joint pain and inflammation."; HEADACHE (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Extreme headaches"; NAUSEA (non-serious) with onset 15Mar2021, outcome "not recovered", described as "nausea"; BACK PAIN (non-serious) with onset 15Mar2021, outcome "not recovered", described as "back pain"; JOINT SWELLING (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Swollen joints"; JOINT STIFFNESS (non-serious) with onset 15Mar2021, outcome "not recovered", described as "increased stiffness in all joints, but the wrists, shoulder and hips are the worst"; DYSPNOEA (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Difficulty breathing"; ASTHENIA (non-serious) with onset 15Mar2021, outcome "not recovered", described as "low energy"; PALPITATIONS (non-serious) with onset 15Mar2021, outcome "not recovered", described as "heart palpitations"; WHEEZING (non-serious) with onset 15Mar2021, outcome "not recovered", described as "wheezing". The events "extreme joint pain and inflammation.", "extreme joint pain and inflammation.", "extreme headaches", "nausea", "back pain", "swollen joints", "increased stiffness in all joints, but the wrists, shoulder and hips are the worst", "difficulty breathing", "low energy", "heart palpitations" and "wheezing" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of arthralgia, inflammation, headache, nausea, back pain, joint swelling, joint stiffness, dyspnoea, asthenia, palpitations, wheezing.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No hospitalization prolonged and no treatment received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-Up (10Nov2021): Follow-up attempts are completed. No further information is expected.